Ao L - Search Results

1

A Qualitative Transcriptional Signature for the Risk Assessment of Precancerous Colorectal Lesions.

Guan Q, Zeng Q, Jiang W, Xie J, Cheng J, Yan H, He J, Xu Y, Guan G, Guo Z, Ao L. Guan Q, et al. Among authors: ao l. Front Genet. 2021 Jan 15;11:573787. doi: 10.3389/fgene.2020.573787. eCollection 2020. Front Genet. 2021. PMID: 33519891 Free PMC article.

2

A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation.

Zhou X, Li B, Zhang Y, Gu Y, Chen B, Shi T, Ao L, Li P, Li S, Liu C, Guo Z. Zhou X, et al. Among authors: ao l. Breast Cancer Res Treat. 2013 Dec;142(3):505-14. doi: 10.1007/s10549-013-2767-8. Epub 2013 Nov 20. Breast Cancer Res Treat. 2013. PMID: 24253811

3

Li H, Zheng T, Chen B, Hong G, Zhang W, Shi T, Li S, Ao L, Wang C, Guo Z. Li H, et al. Among authors: ao l. Br J Cancer. 2014 Jul 29;111(3):525-31. doi: 10.1038/bjc.2014.347. Epub 2014 Jun 24. Br J Cancer. 2014. PMID: 24960404 Free PMC article.

4

Hong G, Chen B, Li H, Zhang W, Zheng T, Li S, Shi T, Ao L, Guo Z. Hong G, et al. Among authors: ao l. PLoS One. 2014 Sep 22;9(9):e108104. doi: 10.1371/journal.pone.0108104. eCollection 2014. PLoS One. 2014. PMID: 25243474 Free PMC article.

5

The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.

Gu Y, Zhang M, Peng F, Fang L, Zhang Y, Liang H, Zhou W, Ao L, Guo Z. Gu Y, et al. Among authors: ao l. Oncotarget. 2015 Feb 10;6(4):2397-406. doi: 10.18632/oncotarget.2963. Oncotarget. 2015. PMID: 25537514 Free PMC article.

6

Individualized identification of disease-associated pathways with disrupted coordination of gene expression.

Wang H, Cai H, Ao L, Yan H, Zhao W, Qi L, Gu Y, Guo Z. Wang H, et al. Among authors: ao l. Brief Bioinform. 2016 Jan;17(1):78-87. doi: 10.1093/bib/bbv030. Epub 2015 May 27. Brief Bioinform. 2016. PMID: 26023086

7

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments.

Ao L, Yan H, Zheng T, Wang H, Tong M, Guan Q, Li X, Cai H, Li M, Guo Z. Ao L, et al. Sci Rep. 2015 Jul 15;5:11895. doi: 10.1038/srep11895. Sci Rep. 2015. PMID: 26173481 Free PMC article.

8

Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post-chemotherapy tissues.

Tong M, Zheng W, Lu X, Ao L, Li X, Guan Q, Cai H, Li M, Yan H, Guo Y, Chi P, Guo Z. Tong M, et al. Among authors: ao l. Oncotarget. 2015 Dec 1;6(38):41216-27. doi: 10.18632/oncotarget.5649. Oncotarget. 2015. PMID: 26515599 Free PMC article.

9

Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer.

Cai H, Li X, Li J, Ao L, Yan H, Tong M, Guan Q, Li M, Guo Z. Cai H, et al. Among authors: ao l. Oncotarget. 2015 Dec 29;6(42):44593-608. doi: 10.18632/oncotarget.6260. Oncotarget. 2015. PMID: 26527319 Free PMC article.

10

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.

Li X, Cai H, Zheng W, Tong M, Li H, Ao L, Li J, Hong G, Li M, Guan Q, Yang S, Yang D, Lin X, Guo Z. Li X, et al. Among authors: ao l. Oncotarget. 2016 Feb 23;7(8):8743-55. doi: 10.18632/oncotarget.7087. Oncotarget. 2016. PMID: 26840027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters